Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.
about
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis.Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes.A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.Elevated transaminases are common in children on prophylactic treatment for tuberculosis.Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral InfarctionNAT2 Genotype and Isoniazid Medication in Children.Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.Highlight report: gene dose response in N-acetylation capacity.The ultra-slow NAT2*6A haplotype is associated with reduced higher cognitive functions in an elderly study group.Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population.Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
P2860
Q27011622-C38E8CB5-43BD-43DC-9441-E9278E703293Q33901424-1B64720C-888C-46EE-B9D3-3311D2C84F46Q35934555-750D24E7-F9F4-496D-B354-BA91D23FA1BCQ38360770-30260FF6-275F-4830-8AE3-EBE2964A552DQ39158128-BF314C49-D9FC-4100-BA06-63607C59AEB3Q40096207-D4E1A286-8D70-459A-A754-5DC59F8FC277Q41068782-405F5423-F91C-4944-89A6-0F9E8DEA1F1EQ41102009-5915E478-93A1-4F17-AD7F-CA46D405DBE5Q41522902-683AB720-02EF-42D1-B3F8-F7217C8F7DA0Q42026631-DBFE4B0D-7A39-4650-AFED-18767433EDD1Q42387608-1E80CAAD-EFDF-4B35-AE56-0804875F50A6Q42696912-6BDE1BAA-A6E2-408A-9475-08D09FE42C0DQ49561038-47018E43-0266-458A-9430-2BFE0B5FDE4AQ50317492-8E04ECED-4F84-4B4D-B092-E4A4B2A55C7BQ51569750-83CB04CB-E252-4F10-8CA3-CFC81BFFF2C9Q52625145-5B65DB46-D607-47F5-9FB5-E0AC2CEC1131Q53734594-85AFE947-4DD4-4018-BAE8-4BFBD51F606AQ53792830-C6D7E7FB-4114-4C12-A991-FC850B85F45A
P2860
Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@en
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@nl
type
label
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@en
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@nl
prefLabel
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@en
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@nl
P2093
P2860
P1476
Slow N-acetyltransferase 2 gen ...... patotoxicity: a meta-analysis.
@en
P2093
Haijian Du
Ouyang Yan
Weifeng Li
Wenjie Huang
Xiaorong Chen
P2860
P2888
P304
P356
10.1007/S11033-012-2433-Y
P577
2013-01-01T00:00:00Z